Glucose-monitoring specialist Dexcom announced it has made a $75 million strategic investment in health-tracking ring maker Oura and established a strategic partnership to enable two-way data flow between Dexcom's continuous glucose monitor (CGM) and the Oura Ring.
Dexcom will contribute $75 million to Oura's Series D funding round, which will bring Oura's valuation to more than $5 billion....
GraphWear announced Monday it raised $20.5 million in Series B funding for its needle-free continuous glucose monitoring platform.
The round was led by Mayfield, with participation from MissionBio Capital, Builders VC and VSC Ventures.
WHAT IT DOES
The startup makes a wearable sensor that it claims can measure glucose molecules on the surface of the skin and provide a read of glucose levels...
Despite the challenges of 2020, Dexcom was able to close the year out with financial growth for both the fourth quarter and the full year, according to its earnings report released Thursday.
In the earnings call, Dexcom’s chairman, president and CEO Kevin Sayer voiced his gratitude to the company for surpassing its goals even under the extreme circumstances last year.
“In any given year, these...
The Centers for Medicare and Medicaid Services has deemed certain therapeutic continuous blood glucose meters (CGMs) as durable medical equipment and thus are eligible for coverage.
It’s not all cut and dry, of course. Eligible devices must fit several definitions: they must be a class III, FDA-approved device, and they must be CGMs that measure blood glucose levels periodically by using sensors...
Germantown, Maryland-based Senseonics, which is working on a long-term implantable continuous glucose monitor called Eversense, has expanded its exclusive distribution agreement with Roche.
Now, Roche will have exclusive rights to promote, market and sell the Eversense product line to diabetes clinics and patients in in most of Europe (excluding Scandinavia and Finland), the Middle East (except...
Photo Credit: Paul Savage Photography
By Padma Nagappan
One of the panels at the recently concluded WLSA Convergence Summit in San Diego focused on how things have changed within the last five years and whether the guidelines the FDA issued last year for devices helps provide clarity in navigating the choppy waters of clearance.
The panel featured two companies that have received 510(k)...
